{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Subject(ID=63684L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Subject(ID=63684L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Subject"},"Meetings":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Meeting(ID=4883L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4883L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Meeting"},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4883L,Language='FR')/Sessions"}},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4883L,Language='FR')/Subjects"}},"ID":"4883","Language":"FR","MeetingNumber":6,"IdSession":5202,"SessionNumber":2,"SessionName":"Session de printemps 2024","Council":1,"CouncilName":"Conseil national","CouncilAbbreviation":"CN","Date":"\/Date(1709510400000)\/","Begin":"1430","Modified":"\/Date(1711982426537)\/","LegislativePeriodNumber":52,"PublicationStatus":"final","MeetingOrderText":"Sixi\u00e8me s\u00e9ance","SortOrder":6,"Location":"N"},"SubjectsBusiness":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20247077,IdSubject=63684L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20247077,IdSubject=63684L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.SubjectBusiness"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20247077,IdSubject=63684L,Language='FR')/Subjects"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20247077,IdSubject=63684L,Language='FR')/Businesses"}},"IdSubject":"63684","BusinessNumber":20247077,"Language":"FR","BusinessShortNumber":"24.7077","Title":"Avenir de la production pharmaceutique de m\u00e9dicaments v\u00e9t\u00e9rinaires","SortOrder":1,"PublishedNotes":null,"Modified":"\/Date(1709277236016)\/","TitleDE":"Fragestunde.\nFrage R\u00fcegsegger Hans J\u00f6rg.\nZukunft der pharmazeutischen\nProduktion von Tierarzneimitteln","TitleFR":"Heure des questions.\nQuestion R\u00fcegsegger Hans J\u00f6rg.\nAvenir de la production\npharmaceutique\nde m\u00e9dicaments v\u00e9t\u00e9rinaires","TitleIT":null}]},"Transcripts":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Transcript(ID=334379L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=334379L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Transcript"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=334379L,Language='FR')/Subjects"}},"MembersCouncil":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=334379L,Language='FR')/MembersCouncil"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=334379L,Language='FR')/Businesses"}},"ID":"334379","Language":"FR","IdSubject":"63684","VoteId":null,"PersonNumber":null,"Type":3,"Text":"<pd_text><p><i>Schriftliche Antwort (Beilage) - R\u00e9ponse \u00e9crite (annexe) </i>[PAGE 189] </p>\n<p>[VS]</p>\n</pd_text>","MeetingCouncilAbbreviation":"N","MeetingDate":"20240304","MeetingVerbalixOid":3826,"IdSession":"5202","SpeakerFirstName":null,"SpeakerLastName":null,"SpeakerFullName":"","SpeakerFunction":null,"CouncilId":null,"CouncilName":null,"CantonId":null,"CantonName":null,"CantonAbbreviation":null,"ParlGroupName":null,"ParlGroupAbbreviation":null,"SortOrder":1,"Start":null,"End":null,"Function":null,"DisplaySpeaker":null,"LanguageOfText":"DE","Modified":"\/Date(1774876811948)\/","StartTimeWithTimezone":null,"EndTimeWithTimezone":null,"VoteBusinessNumber":null,"VoteBusinessShortNumber":null,"VoteBusinessTitle":null}]},"ID":"63684","Language":"FR","IdMeeting":"4883","VerbalixOid":738485,"SortOrder":90,"Modified":"\/Date(1774876811943)\/"}}